Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Altering The Transition From Acute to Chronic Pain (ATTAC-Pain): A Randomized Clinical Trial of Duloxetine for the Treatment and Prevention of Musculoskeletal Pain

NCT03315533 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT03315533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03315533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Altering The Transition From Acute to Chronic Pain (ATTAC-Pain): A Randomized Clinical Trial of Duloxetine for the Treatment and Prevention of Musculoskeletal Pain
Lead sponsor
Rhode Island Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 19, 2018
Completion date
April 1, 2019
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

musculoskeletal pain